CTRI/2016/04/006867已完成4 期
A prospective, multicentre postmarketingsurveillance to monitorsafety associated with usage of Simponi�® (golimumab injection50mg) in Indian subjects with Rheumatoid Arthritis as per locallyapproved prescribing information
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Pms
入排标准
入选标准
- •Participants of rheumatoid arthritis (RA), who are being prescribed and initiated on golimumab as per independent clinical judgment of treating Physicians based on the locally approved
- •Prescribing Information Participants
- •must sign an informed consent form (ICF) indicating that he or she understands the purpose of and procedures required for the study and willing to participate in the study
排除标准
- •Participants participating or planning to participate in any interventional drug trial during the course of this study
研究者
相似试验
进行中（未招募）
1 期
Post marketing surveillance to collect safety information after vaccination with Bexsero administered in routine care and according to prescribing information in Korea.The study will collect real-world post-vaccination adverse events.EUCTR2023-000765-14-Outside-EU/EEAGlaxoSmithKline Biologicals SA
进行中（未招募）
4 期
A post marketing study to monitor safety of Abiraterone Acetate (Zytiga) in Indian patients with Prostate CancerCTRI/2016/04/006854Johnson Johnson Private Limited
已完成
4 期
Post Marketing Study of Perampanel in Patients with EpilepsyCTRI/2019/01/016844Eisai Pharmaceutical India Limited200
招募中
4 期
A MULTI-CENTER, POST MARKETING SURVEILLANCE STUDYTO MONITOR THE SAFETY AND PERFORMANCEOF THE BARRICAID® ARD IN THE TREATMENT OF BACK ANDRADICULAR PAIN CAUSED BY PRIMARY LUMBAR DISCHERNIATIOlumbal disc herniation10009720herniaNL-OMON32568Canisius Wilhelmina Ziekenhuis30
已完成
4 期
Superia: Sirolimus Eluting Coronary Stent System (SSECSS) India Post Marketing RegistryCTRI/2012/01/002393Innvolution Med System200